Psychopharmacology in Psychodermatology Journal Articles

abstract

• Background: The management of psychodermatologic disease often involves the use of psychotropics by dermatologists. A general approach to the psychopharmacologic management of psychodermatological disease may be of assistance to the dermatologist. Objective: We review and provide a current psychopharmacologically based approach to management of common psychopathologies associated with psychodermatologic disorders, common side effects, and potential drug interactions that may occur with selected psychotropics. Methods: Using relevant MeSH terms, we performed a review of the literature from 1980 to 2006. Results and Conclusions: Effective psychopharmacologic management of psychodermatologic disease involves identifying and basing treatment on the associated psychopathology; familiarity with a variety of psychotropic agents, including antidepressants, anxiolytics, and antipsychotics; and the involvement of a psychiatrist when possible.

authors

• Shukla, Rahul
• Sasseville, Denis

status

• published 

publication date

• November 2008

has subject area

• Anxiety (MeSH)
• Delusions (MeSH)
• Depression (MeSH)
• Dermatology (MeSH)
• Humans (MeSH)
• Mental Disorders (MeSH)
• Obsessive-Compulsive Disorder (MeSH)
• Psychopathology (MeSH)
• Psychopharmacology (MeSH)
• Psychophysiologic Disorders (MeSH)
• Psychotropic Drugs (MeSH)
• Skin Diseases (MeSH)
• Time Factors (MeSH)

published in

• Medical and Surgical Dermatology  Journal

keywords

• Anxiety
• Delusions
• Depression
• Dermatology
• Humans
• Mental Disorders
• Obsessive-Compulsive Disorder
• Psychopathology
• Psychopharmacology
• Psychophysiologic Disorders
• Psychotropic Drugs
• Skin Diseases
• Time Factors

Digital Object Identifier (DOI)

• 10.2310/7750.2008.07062

PubMed ID

• 19317947

start page

• 255

end page

• 267

volume

• 12

issue

• 6